Abstract:BACKGROUND: The objective of this work was to examine the relationship between obstructive sleep apnea (OSA) and inflammatory markers and quality of life in patients with acute coronary syndrome, especially undergoing percutaneous coronary intervention. METHODS: One hundred eighteen subjects were admitted with acute coronary syndrome over 1 y who had symptoms of OSA and positive polysomnography on admission. Of these subjects, 53 underwent primary percutaneous coronary intervention during their admission, and 65 had medical management. We then compared inflammatory markers by OSA status. We also assessed cardiac symptoms using the Seattle Angina Questionnaire and sleep symptoms using the Epworth Sleepiness Scale. RESULTS: Subjects in the percutaneous coronary intervention group had a higher oxygen desaturation index (ODI) (P = .02) and apnea-hypopnea index (AHI) (P = .048) compared with those in the medical management group. In percutaneous coronary intervention subjects, the moderate-severe OSA group (AHI >= 15/h) had a higher hematocrit (P = .047), homocysteine (P = .01), and high-sensitivity C-reactive protein (P = .045) compared with those with no or mild OSA (AHI < 15/h). There was a significant correlation between high-sensitivity C-reactive protein and both AHI (r = 0.46, P = .001) and ODI (r = 0.47, P < .001). Those with moderate-severe OSA had higher Epworth Sleepiness Scale (P = .002), greater physical limitation (P = .01), and lower treatment satisfaction and disease perception (P = .007), as judged by subscales of the Seattle Angina Questionnaire, compared with those with no or mild OSA. Finally, subjects undergoing percutaneous coronary intervention with lower AHI (r = 0.48, P < .001) and ODI (r = 0.49, P < .001) reported higher treatment satisfaction. CONCLUSIONS: Subjects with acute coronary syndrome undergoing percutaneous coronary intervention who had moderate-severe OSA showed higher levels of inflammatory mediators and lower treatment satisfaction and disease perception. These factors may increase the risk of adverse sequelae by increasing the systemic inflammatory response. (C) 2016 Daedalus Enterprises

Biochemical Indexes in Coronary Heart Disease Patients with Obstructive Sleep Apnoea

Study about the change of lipid metabolism in patients of obstructive sleep apneahypopnea syndrome

Effects of obstructive sleep apnea on inflammatory markers in patients with acute coronary syndrome

Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance

Characteristics of Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea Syndrome

The Relationship Between Obstructive Sleep Apnea Hypopnea Syndrome and Inflammatory Markers and Quality of Life in Subjects With Acute Coronary Syndrome.

To Study on the Association Between the Carotid Intima-Media Thickness and Adult Obstructive Sleep Apnea Hypoventilation Syndrom

Clinical Analysis of 69 Obstructive Sleep Apnea Hypopnea Syndrome Patients with Impaired Glucose Tolerance

Lipid metabolism and plaque development of carotid artery in patients with obstructive sleep apnea-hypopnea syndrome

Influence of Obstructive Sleep Apnea hypopnea Syndrome on Cardiovascular Risk Factors

Influnce of Obstructive Sleep Apnea Hypopnea Syndrome to the Levels of Serum Uric Acid and Blood Lipid

Changes in homocysteine levels in patients with ischemic cerebral disease and obstructive sleep apnea-hypopnea syndrome

Changes of serum myocardial enzymes and uric acid in patients with severe obstructive sleep apnea hypopnea syn-drome complicated with hypertension

Changes and implication of serum heart type fatty acid binding protein, high-sensitivity C-reactive protein in patients with obstructive sleep apnea hypopnea syndrome

Alterations of IGF-1, Complement C3 and Superoxide Dismutase in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome.

Clinical Observation of Glucose Metabolism Disorders in Elderly Patients with Obstructive Sleep Apnea Disorder

Serum Inflammatory Factors in Patients with Obstructive Sleep Apnea Syndrome and Coronary Heart Disease

Effects of Continuous Positive Airway Pressure on Serum Inflammatory Factors in Coronary Heart Disease Patients Complicated with Obstructive Sleep Apnea-Hypopnea Syndrome

Analysis on Correlation Between Obstructive Sleep Apnea Hypopnea and Metabolic Syndromes in Male Patients

Correlation Analysis of Polysomnography Indexes in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Lipid Metabolism Disorder in Non-obese Type Obstructive Sleep Apnea Hypopnea Syndrome